Monday, February 17, 2025

Gene-edited cells that evade rejection show promise in type 1 diabetes

Date:


A transmission electron micrograph of a section through pancreas tissue, showing cells that produce insulin

STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY/Alamy

The first human trial of insulin-producing cells that have been gene-edited to evade immune attack is a success so far. The cells have survived and produced insulin for a month after being injected into a 42-year-old man with type 1 diabetes early in December.

As a precaution, only a small number of insulin-producing beta cells were injected into a forearm muscle in this initial test, so the man still needs insulin injections. It also remains to be seen how long the…



Source link

Share post:

spot_img

Popular

More like this
Related

Apple’s foldable iPhone: New leaks reveal unique hinge design, camera setup, expected release

Apple has long kept its foldable iPhone plans...

Creating Personalized Experiences with ChatGPT API: Unlocking Potential with MNAPI

In recent years, artificial intelligence (AI) has revolutionized the...

Vivo T4x 5G to Launch in India Soon; Price Range, Availability Confirmed

Vivo T4x 5G has been teased to launch...